Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia.
Shamaa
Lobna A Abou
LA
Immunology Department, Medical Research Institute, Alexandria University, Egypt.
Hussein
Amina El-Sayed
Ael-S
Balbaa
Ola A
OA
Farahat
Nahla M
NM
Ali
Mohamed Abd El-Wahid
MA
D000368:Aged; D017209:Apoptosis / Q000187:drug effects*; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D015847:Interleukin-4 / Q000378:metabolism*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood / Q000175:diagnosis / Q000378:metabolism* / Q000473:pathology*; D007958:Leukocyte Count; D007963:Leukocytes, Mononuclear / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology*; D018655:Lymphocyte Count; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010976:Platelet Count; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000494:pharmacology
D006454:Hemoglobins; C508598:IL4 protein, human; D015847:Interleukin-4; D014740:Vidarabine; C024352:fludarabine